• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec29
Greenwich LifeSciences Extends Lock-Up Period to Support Immunotherapy Trial
11:00
Nov15
Greenwich Lifesciences released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.8527
04:00
Greenwich Lifesciences released FY2025 Q3 earnings on November 14, 2025 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -0.3043 (forecast USD -0.36)
04:00
Oct9
Greenwich Life Sciences Assessing Preventative Breast Cancer Immunotherapy GLSI-100
10:37
Aug15
Greenwich Lifesciences released FY2025 Semi-Annual earnings on August 14, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.5488
03:00
Greenwich Lifesciences released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.301 (forecast USD -0.24)
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -4.152 M, EPS -0.3043

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -4.025 M, EPS -0.301

May20
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.258 M, EPS -0.2473

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
11.296
+106.89%
+5.836
BUUU
16.200
+90.81%
+7.710
PFSA
0.1261
+84.63%
+0.058
AEHL
2.010
+77.88%
+0.880
AFJK
70.000
+60.37%
+28.520
DAIC
0.5849
+47.89%
+0.187
ULY
2.595
+43.37%
+0.785
MENS
3.950
+42.09%
+1.170
ONTF
8.020
+36.86%
+2.160
FLYE
7.070
+33.77%
+1.785
View More